Corporate Profile
Message
Business Operations
News
Contact us
JP
EN
News
February 7, 2018
Lupin and Yoshindo’s JV - YL Biologics announces successful outcome of global Phase III study for Etanercept biosimilar in Rheumatoid Arthritis
”read more” link to press release PDF.